Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf H Rogowski

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|February 28, 2014
Is individualized medicine more cost-effective? A systematic reviewMaximilian H M Hatz, Katharina Schremser, Wolf H Rogowski
Nature Reviews. Genetics|June 10, 2009
Challenges of translating genetic tests into clinical and public health practiceWolf H Rogowski, Scott D Grosse, Muin J Khoury
International Journal of Technology Assessment in Health Care|October 19, 2011
The role of health technology assessment in coverage decisions on newborn screeningKatharina E Fischer, Scott D Grosse, Wolf H Rogowski
Health Policy (Amsterdam, Netherlands)|May 14, 2013
Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysisKatharina E Fischer, Wolf H Rogowski, Reiner Leidl, et al.
BMC Health Services Research|October 29, 2015
Early decision-analytic modeling - a case study on vascular closure devicesAlina Brandes, Moritz F Sinner, Stefan Kääb, et al.
Pharmacoeconomics|July 2, 2016
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic EvaluationsCynthia P Iglesias, Alexander Thompson, Wolf H Rogowski, et al.
European Journal of Human Genetics : EJHG|August 8, 2013
Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?Wolf H Rogowski, Scott D Grosse, Jörg Schmidtke, et al.
BMC Medical Ethics|December 24, 2013
What is personalized medicine: sharpening a vague term based on a systematic literature reviewSebastian Schleidgen, Corinna Klingler, Teresa Bertram, et al.
BMC Health Services Research|November 20, 2016
Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysisAlina Brandes, Florian Koerber, Larissa Schwarzkopf, et al.
Diabetes Care|January 20, 2018
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in GermanyKatharina Kähm, Michael Laxy, Udo Schneider, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|February 28, 2014
Is individualized medicine more cost-effective? A systematic reviewMaximilian H M Hatz, Katharina Schremser, Wolf H Rogowski
Nature Reviews. Genetics|June 10, 2009
Challenges of translating genetic tests into clinical and public health practiceWolf H Rogowski, Scott D Grosse, Muin J Khoury
International Journal of Technology Assessment in Health Care|October 19, 2011
The role of health technology assessment in coverage decisions on newborn screeningKatharina E Fischer, Scott D Grosse, Wolf H Rogowski
Health Policy (Amsterdam, Netherlands)|May 14, 2013
Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysisKatharina E Fischer, Wolf H Rogowski, Reiner Leidl, et al.
BMC Health Services Research|October 29, 2015
Early decision-analytic modeling - a case study on vascular closure devicesAlina Brandes, Moritz F Sinner, Stefan Kääb, et al.
Pharmacoeconomics|July 2, 2016
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic EvaluationsCynthia P Iglesias, Alexander Thompson, Wolf H Rogowski, et al.
European Journal of Human Genetics : EJHG|August 8, 2013
Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?Wolf H Rogowski, Scott D Grosse, Jörg Schmidtke, et al.
BMC Medical Ethics|December 24, 2013
What is personalized medicine: sharpening a vague term based on a systematic literature reviewSebastian Schleidgen, Corinna Klingler, Teresa Bertram, et al.
BMC Health Services Research|November 20, 2016
Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysisAlina Brandes, Florian Koerber, Larissa Schwarzkopf, et al.
Diabetes Care|January 20, 2018
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in GermanyKatharina Kähm, Michael Laxy, Udo Schneider, et al.
Pageof 3